The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access
The trial showed positive outcomes at one year in obese male and female patients with diabetes compared to AV fistulas.
Read the full article » | Posted 09-18-2026
Related Articles
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
- Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
- Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026
- HollyTM Implantable Continuous Dialysis System Could be Ready for Human Trials Soon Posted 04-14-2026